Overview

EZEN helps a medical devices client secure a First submission 510(K) by Eliminating Critical Vulnerabilities in their Connected Medical Devices

Vulnerability management, secure engineering, FDA-aligned documentation and security monitoring for connected devices running legacy firmware.

Services: Vulnerability & Patch Management | Secure Device Engineering | FDA Cybersecurity Documentation | Security Monitoring & Incident Response | Gap Assessment and Risk Stratification

Legacy firmware with unpatched CVEs, hard-coded credentials and unencrypted PHI transmission put both patient data and regulatory readiness at risk. EZEN Digital supported the remediation, the submission documentation and the monitoring that keeps the product secure after release.

100%

Critical vulnerabilities eliminated

Within 90 days of deployment

67%

Faster incident response

Compared with the pre-engagement baseline

510(k)

FDA clearance, first submission

No resubmission reported

Summary

What was at risk, what EZEN did, what was reported

Connected medical devices running legacy firmware with unpatched CVEs, hard-coded credentials and unencrypted PHI transmission carry risk to patient data and to regulatory readiness. The product also showed non-conformance against FDA 510(k), IEC 62304, UL 2900-2-1 and AAMI TIR57 expectations.

EZEN Digital supported the work through SBOM-driven vulnerability and patch management, secure device and application engineering, regulatory compliance documentation, and real-time security monitoring and response. The reported results were 100% elimination of critical vulnerabilities within 90 days of deployment, 67% faster incident response against the pre-engagement baseline, and FDA 510(k) clearance on the first submission with no resubmission.

Business and Technical Challenges

Security gaps at every layer of the product

The gaps ran from the firmware and embedded applications to the vulnerability process, the data moving across device networks, and the documentation a submission depends on.

icon1-07

Legacy firmware and CVE exposure

• Legacy firmware with unpatched CVEs on connected devices
• Insecure boot sequences
• Unvalidated software updates

icon1-05

Device and embedded application security

• Improper input and output validation in embedded applications
• Unauthorized authentication and session hijacking risks
• Hard-coded credentials in device firmware

icon1-02

Vulnerability and patch management

• Inadequate vulnerability assessment and patch management lifecycle

icon1-06

Patient data protection

• Unencrypted PHI transmission across device networks
• Limited audit trail visibility and access controls

icon1-01

Regulatory documentation and readiness

• Non-conformance identified against FDA 510(k), IEC 62304, UL 2900-2-1 and AAMI TIR57

Closing these gaps required engineering remediation, regulatory evidence and ongoing security operations to be planned together.

What EZEN Delivered

Four connected workstreams

EZEN treated remediation, secure engineering, regulatory documentation and monitoring as one program rather than separate checks.

Vulnerability and patch management

• SBOM creation, CVE tracking and controlled patch deployment
• Automated vulnerability scanning with Nessus, Qualys and Trivy

Secure device engineering (SDLC)

• Threat modeling, SAST/DAST and OWASP Top 10 validation
• Zero-trust network architecture and encrypted data flows

Regulatory compliance architecture

• HIPAA, GDPR, IEC 62304, UL 2900-2-1 and FDA premarket cybersecurity guidance
• Gap analysis, remediation roadmap and submission-ready documentation

Real-time monitoring and response

• SIEM integration, continuous device telemetry and anomaly detection
• Incident response playbooks and forensic investigation capability

Measurable Business Outcomes

Reported results

100%

Critical vulnerabilities eliminated

Identified critical vulnerabilities were eliminated within 90 days of deployment.

67%

Faster incident response

Incident response time improved by 67% compared with the pre-engagement baseline.

510(k)

Supported FDA 510(k) submission

FDA 510(k) clearance was reported without resubmission.

EZEN treated remediation, secure engineering, regulatory documentation and monitoring as one program rather than separate checks.

What This Means for Medical Device Manufacturers

Security that lasts beyond the submission

Connected medical devices need cybersecurity controls that can be maintained across the product lifecycle, not only assessed before a regulatory submission. This work combined engineering remediation, vulnerability management, regulatory documentation and security operations in one program

Strengthen Your Medical Device Product Security with EZEN.

Whether your team is addressing legacy firmware vulnerabilities, preparing cybersecurity evidence for a submission, or strengthening postmarket vulnerability management, EZEN can support the engineering and documentation work.

Contact Us

Contact Us